In addition to his position at Drexel University College of Medicine, Dr. Goldenberg is the Charles E. Flowers Professor of Obstetrics and Gynecology and director of the Center for Research On Women's Health at the University of Alabama at Birmingham (UAB). He is also a professor of public health and preventive medicine. He served as director of the Department of Maternal and Child Health within the Alabama State Department of Public Health from 1977 to 1981.
Dr. Goldenberg has been a member of the Institute of Medicine since 1997, served as chairman of the IOM Pediatrics and Ob-Gyn sections from 1998 to 2002, and has been a member of the IOM committee on improving birth outcomes in developing countries since 1999.
He has published more than 400 peer-reviewed journal articles, predominantly related to infant mortality, preterm delivery, growth retardation and maternal to child transmission of HIV, as well as an equivalent number of abstracts, book chapters, etc. He also has extensive experience in working on multi-center research networks.
With Dr. Goldenberg as P.I., UAB was chosen by the March of Dimes to be one of five centers participating in the Prematurity Prevention study in the early 1980s. Of the five sites, UAB recruited 40 percent of the total patients for that study and has more publications from that data set then all other sites combined.
In the mid 1980s, Dr. Goldenberg was the P.I. for the Alabama component of the NICHD-funded study of risk factors for growth retardation performed in collaboration with two sites in Norway and one in Sweden. UAB investigators have used this data set and biologic samples for more than 50 publications, once again leading all other combined study sites in the number of publications.
Dr. Goldenberg was co-P.I. for the 14-site MFMU Network for over eight years. During that time, UAB was generally the top recruiter among all centers and was clearly the leading site in terms of productivity.
Dr. Goldenberg was the P.I. for the Preterm Prediction Study, which was completed on time and under budget. More publications, abstracts and oral presentations have come from this study than any other MFMU Network study. UAB also participated in the NICHD CPEP study of calcium to prevent preeclampsia and was the leading patient recruiter among the five sites that participated in the study. Robert Goldenberg and John Hauth were the Alabama Co-P.I.s for that study.
In the mid-1990s, the UAB Department of Obstetrics and Gynecology with Robert Goldenberg as P.I. organized the AHCPR Low Birthweight Patient Outcomes Research Team (PORT), which required the creation of a multidisciplinary team spanning a number of departments, schools and universities. This PORT, acknowledged by AHCPR as one of its most successful, brought together investigators from UAB, Vanderbilt and Albert Einstein universities to conduct a large number of studies related to low birthweight with special emphasis on minority pregnancies. Much of the national and international emphasis placed on increasing the use of corticosteroids for fetal maturation came from this group, which ultimately had more than 70 publications related to the PORT. The databases created by the PORT are still being used today.
More recently, Dr. Goldenberg has participated in the NICHD/NIAID HIVNET/HPTN networks, studying HIV in Africa. Dr. Goldenberg is the P.I. for a four-site study (Dar es Salaam, Tanzania; Llongwe, Malawi; Blantyre, Malawi; Lusaka, Zambia) in which a randomized trial of conventional antibiotics was carried out in nearly 3,000 HIV-positive pregnant women.
In The News